- Trade rules and agreements can be crucial in determining access to different medical technologies, when a trade restriction is not applied correctly or when barriers are put in place which make it difficult for patients to access technologies, this can have an important impact on the sector. MedTech Europe is engaged in trade negotiations to ensure access to medical technologies around the globe.. This has been the case during the EU-Japan trade dialogue, as well as on World Trade Organisation activities on technical barriers to trade issues.
- The Transatlantic Trade and Investment Partnership (TTIP), currently under negotiation, could provide a major boost to trade in medical devices and in vitro diagnostics: both industries are specifically mentioned under an initiative to ensure greater transparency in the discussions.
- MedTech Europe is also involved in discussions at the level of the World Customs Organization (WCO) to ensure a clear and consistent application of customs rules to medical technologies so as to facilitate trade, looking at questions such as tariffs and classification of devices under the harmonized system of nomenclature.